Cargando…

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study

INTRODUCTION: The disease trajectory of diabetic kidney disease (DKD) shows a high interindividual variability not sufficiently explained by conventional risk factors. Clonal hematopoiesis of indeterminate potential (CHIP) is a proposed novel cardiovascular risk factor. Increased kidney fibrosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denicolò, Sara, Vogi, Verena, Keller, Felix, Thöni, Stefanie, Eder, Susanne, Heerspink, Hiddo J.L., Rosivall, László, Wiecek, Andrzej, Mark, Patrick B., Perco, Paul, Leierer, Johannes, Kronbichler, Andreas, Steger, Marion, Schwendinger, Simon, Zschocke, Johannes, Mayer, Gert, Jukic, Emina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039487/ https://www.ncbi.nlm.nih.gov/pubmed/35497780 http://dx.doi.org/10.1016/j.ekir.2022.01.1064

Ejemplares similares

Response
por: Vogi, Verena, et al.
Publicado: (2022)

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course
por: Petzer, Verena, et al.
Publicado: (2021)

International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe
por: Thöni, Stefanie, et al.
Publicado: (2023)

Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity
por: Feldkamp, Jasper David, et al.
Publicado: (2022)

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant
por: Locher, Maurus, et al.
Publicado: (2020)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
por: Sella, Tal, et al.
Publicado: (2022)

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
por: Huang, Yi-Chun, et al.
Publicado: (2021)

Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury
por: Vlasschaert, Caitlyn, et al.
Publicado: (2023)

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2019)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
por: Miller, Peter G., et al.
Publicado: (2022)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
por: Komic, Luka, et al.
Publicado: (2023)

Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
por: Swaminathan, Aparna C., et al.
Publicado: (2023)

Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers
por: Kerschbaum, Julia, et al.
Publicado: (2020)

Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
por: Burns, Sarah S., et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2021)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
por: Uddin, M d Mesbah, et al.
Publicado: (2022)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
por: Kuhnert, Stefan, et al.
Publicado: (2022)

Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
por: Schenz, Judith, et al.
Publicado: (2022)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
por: Schuermans, Art, et al.
Publicado: (2023)

Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”
por: Vlasschaert, Caitlyn, et al.
Publicado: (2022)

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
por: Burns, Sarah S., et al.
Publicado: (2020)

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative
por: Haring, Bernhard, et al.
Publicado: (2021)

Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation
por: Goldman, Elisabeth A., et al.
Publicado: (2023)

Association of Clonal Hematopoiesis of Indeterminate Potential with Incident Heart Failure with Preserved Ejection Fraction
por: Reiner, Alex P., et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
por: Perco, Paul, et al.
Publicado: (2018)

Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
por: Park, Derek S., et al.
Publicado: (2019)

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
por: Nakao, Tetsushi, et al.
Publicado: (2022)

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
por: Gagnon, Marie-France, et al.
Publicado: (2022)

Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
por: Li, Yong, et al.
Publicado: (2022)

P1642: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL ARE ASSOCIATED WITH INCREASED NETOSIS IN PATIENTS WITH CARDIOVASCULAR EVENTS
por: Marti, Severine, et al.
Publicado: (2023)

Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
por: von Scheidt, Moritz, et al.
Publicado: (2023)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gs8gc75isnetud20kqbasknq2m